Drug companies are this morning braced for a huge change in the way that drugs are priced in an unwelcome report from the Office of Fair Trading.Reports last night suggested that the OFT was poised to recommend sweeping changes to the Pharmaceutical Price Regulation Scheme (PPRS), under which the prices paid by the NHS are determined.>>> Discuss This Story
